
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260729
DTSTAMP:20251107T221936Z
CREATED:20251107T221919Z
LAST-MODIFIED:20251107T221936Z
UID:10000328-1784851200-1785283199@oncodaily.com
SUMMARY:ESMO Course in Medical Oncology for Medical Students 2026
DESCRIPTION:The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive\, four-day residential educational program taking place from July 24 to 28\, 2026\, in Valencia\, Spain. Organized by the European Society for Medical Oncology (ESMO)\, the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez Bayona (Spain)\, the course provides a high-standard\, interactive educational program—including state-of-the-art lectures\, clinical case discussions\, and dedicated workshops—with the primary goal of providing insight into the field of medical oncology and motivating students to commit to this fast-evolving specialty.
URL:https://oncodaily.com/event/esmo-course-404879
LOCATION:INCLIVA Biomedical Research Institute\, C. de Menéndez y Pelayo\, 4\, Valencia\, 46010\, Spain
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/esmo.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260803
DTEND;VALUE=DATE:20261013
DTSTAMP:20260720T142608Z
CREATED:20260720T142239Z
LAST-MODIFIED:20260720T142608Z
UID:10000802-1785715200-1791849599@oncodaily.com
SUMMARY:ESMO Academy 2026
DESCRIPTION:The ESMO Academy 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place virtually from 3 August to 12 October 2026. \nThe programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty\, covering major tumour types\, clinical trial methodology\, treatment principles\, pharmacokinetics\, drug interactions\, and topics relevant to the ESMO Examination. Access is initially limited to participants registered for the ESMO Examination 2026\, while the modules will become available to all ESMO members from November 2026. Registered participants will receive access details closer to the course start date.
URL:https://oncodaily.com/event/esmo-academy-2026-546719
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_21_08-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260902T183000
DTEND;TZID=America/Halifax:20260902T183000
DTSTAMP:20260721T141827Z
CREATED:20260721T141827Z
LAST-MODIFIED:20260721T141827Z
UID:10000808-1788373800-1788373800@oncodaily.com
SUMMARY:ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place live on 2 September 2026 at 18:30 CEST. \nThe session will examine the reliability of current HRD testing\, the role of PARP inhibitors in maintenance therapy\, and the emerging potential of antibody–drug conjugates for patients with HRD-negative advanced ovarian cancer. Faculty include Isabelle L. Ray-Coquard\, Charlie Gourley\, Robert Louis Coleman\, and Kathleen Nadine Moore. Registration is available exclusively to ESMO members\, and live participants will receive a certificate of attendance and two ESMO-MORA Category 1 points. \nRegister Now.
URL:https://oncodaily.com/event/ovarian-cancer-2026-547749
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/pxbee_2026-07-21_18-11-08.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260912
DTSTAMP:20251126T131416Z
CREATED:20251126T131341Z
LAST-MODIFIED:20251126T131416Z
UID:10000410-1788998400-1789171199@oncodaily.com
SUMMARY:Molecular Analysis for Precision Oncology Congress 2026
DESCRIPTION:The Molecular Analysis for Precision Oncology (MAP) Congress 2026\, co-organized by the European Society for Medical Oncology (ESMO)\, Cancer Research UK (CRUK)\, and Unicancer\, is scheduled for 10–11 September 2026 in London\, United Kingdom. \nThis high-level\, two-day meeting will serve as a platform for experts in oncology\, molecular diagnostics\, and precision medicine to converge and exchange ideas. \nThe primary focus of the congress is to share advances in cancer research\, strengthen interdisciplinary connections\, and accelerate the translation of molecular insights – particularly concerning molecular profiling\, biomarker discovery\, and personalized treatment strategies – into routine clinical practice to improve global patient care.
URL:https://oncodaily.com/event/precision-oncology-416782
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/MAP2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260918
DTEND;VALUE=DATE:20260920
DTSTAMP:20260126T222126Z
CREATED:20260126T222113Z
LAST-MODIFIED:20260126T222126Z
UID:10000627-1789689600-1789862399@oncodaily.com
SUMMARY:ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
DESCRIPTION:The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich\, Switzerland\, from September 18–19\, 2026. \nChaired by Natalie Cook and Benedikt Westphalen\, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases\, from diagnosis to treatment\, according to current standards of care. \nThe program focuses on the reshaping of cancer care through tumour-agnostic therapies andprecision oncology\, offering participants the opportunity to learn from leaders in the field while earning 10 ESMO-MORA category 1 points. Applications for the course open with a deadline of June 3\, 2026\, and successful applicants benefit from complimentary registration and accommodation.
URL:https://oncodaily.com/event/esmo-preceptorship-447566
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261001
DTSTAMP:20260721T145557Z
CREATED:20260721T145538Z
LAST-MODIFIED:20260721T145557Z
UID:10000809-1790640000-1790812799@oncodaily.com
SUMMARY:ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
DESCRIPTION:The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29–30 September 2026 in Lugano\, Switzerland. \nThe course will focus on managing cancer-related symptoms\, cachexia\, nutritional needs\, treatment toxicities\, palliative care\, end-of-life preparation\, and communication with patients and families. Applications close on 26 July 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 11 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/cancer-patients-2026-547812
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-06_43_45-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260127T204424Z
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-448014
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T160010Z
CREATED:20260721T160010Z
LAST-MODIFIED:20260721T160010Z
UID:10000811-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on treatment sequencing\, the biology of metastatic breast cancer\, targeted therapy safety and adverse-event management\, and multidisciplinary approaches to improving patient outcomes. Applications close on 21 August 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 10 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/metastatic-breast-cancer-2026-547927
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-07_50_11-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T161206Z
CREATED:20260721T161206Z
LAST-MODIFIED:20260721T161206Z
UID:10000812-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
DESCRIPTION:The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026\, oorganized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC\, biomarker-driven treatment using NGS\, immunohistochemistry\, and liquid biopsy\, and emerging therapies such as antibody–drug conjugates\, bispecific antibodies\, cellular therapies\, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST\, and non-local participants may receive a travel grant of up to €600. \nApply Now.
URL:https://oncodaily.com/event/advanced-nsclc-547940
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-08_06_59-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260127T204055Z
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodaily.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261113
DTSTAMP:20260127T203943Z
CREATED:20260127T203943Z
LAST-MODIFIED:20260127T203943Z
UID:10000635-1794355200-1794527999@oncodaily.com
SUMMARY:ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona
DESCRIPTION:The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona\, Spain\, from November 11–12\, 2026. \nThis specialized educational program is co-chaired by Simon Ekman\, Lizza Hendriks\, and Natasha Leighl\, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies for brain metastases originating from lung and breast malignancies. The course is designed to address the clinical challenges of managing central nervous system involvement\, highlighting the latest research\, systemic therapies\, and multidisciplinary approaches essential for optimizing patient outcomes in these complex cases. \nApplication.
URL:https://oncodaily.com/event/brain-metastases-448007
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-8.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20251127T193815Z
CREATED:20251127T193756Z
LAST-MODIFIED:20251127T193815Z
UID:10000412-1794787200-1795046399@oncodaily.com
SUMMARY:ESMO AI and Digital Oncology Congress 2026
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18\, 2026\, in Berlin\, Germany. \nThis congress is designed as a central meeting point that facilitates the exchange of the latest research\, promotes ethical dialogue\, and highlights technological innovation in cancer care. \nIt brings together healthcare and digital health experts from around the world to foster collaboration\, inspire learning\, and empower oncology professionals to stay ahead in the rapidly evolving digital transformation of medicine. \nThe specific congress venue within Berlin is expected to be announced on the official European Society for Medical Oncology (ESMO) website closer to the event date.
URL:https://oncodaily.com/event/esmo-417477
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260105T000508Z
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodaily.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodaily.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20251211T194040Z
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodaily.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270917
DTEND;VALUE=DATE:20270922
DTSTAMP:20251127T194628Z
CREATED:20251127T194612Z
LAST-MODIFIED:20251127T194628Z
UID:10000413-1821139200-1821571199@oncodaily.com
SUMMARY:ESMO Congress 2027
DESCRIPTION:The ESMO Congress 2027 will take place in Barcelona\, Spain\, from September 17–21\, 2027. \nThis event is recognized as a leading global oncology meeting that serves as a platform for progress by showcasing the latest breakthroughs in oncology research\, clinical practice\, and patient care. The congress brings together a diverse community\, including clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry representatives. \nParticipants can anticipate a dynamic program featuring: \n\nImpactful new data from oncology research.\nInteractive educational sessions.\nUnique networking opportunities.\nA dynamic exhibition area.\n\nBy attending\, participants will gain first-hand insights into the most recent advances and contribute to shaping the future of oncology worldwide.
URL:https://oncodaily.com/event/esmo-congress-2027-417485
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR